• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎链球菌实验室诱导突变体中的高水平替利霉素耐药性。

High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.

作者信息

Walsh Fiona, Willcock Joanne, Amyes Sebastian

机构信息

Department of Medical Microbiology, Medical School, University of Edinburgh, Edinburgh EH8 9AG.

出版信息

J Antimicrob Chemother. 2003 Sep;52(3):345-53. doi: 10.1093/jac/dkg348. Epub 2003 Aug 13.

DOI:10.1093/jac/dkg348
PMID:12917252
Abstract

Resistance to macrolides in Streptococcus pneumoniae is usually mediated by methylation of 23S ribosomal RNA, encoded by the erm(B) methylation gene, or by efflux mediated by the mef(A) gene. Changes in the L4 and L22 ribosomal proteins have also been associated with macrolide resistance and reduced telithromycin activity. This study generated in vitro mutants from three parent strains of S. pneumoniae: 02J1175 [mef(A) +], 02J1095 [erm(B) +] and NCTC 13593 (macrolide susceptible). The erm(B) and the erm(B) upstream region, the mef(A) genes and the mef(A) upstream and downstream regions, the 23S rRNA genes encoding domains II and V and the L4 and L22 genes of the telithromycin-resistant strains were all amplified by PCR and all, except the mef(A) upstream and downstream regions, were sequenced. No changes were present in any of the genes of the mef(A) + mutants. No changes were found in the erm(B) genes, the 23S rRNA genes or the L4 protein genes of the erm(B) + mutants. However, a Lys-94 to Gln-94 amino acid mutation did occur in a mutant derived from erm(B) + with a telithromycin MIC of >32 mg/L. A 210 base pair deletion in the erm(B) upstream region was also present in this strain. We believe this is the first incidence of a Lys-94 to Gln-94 change in L22 associated with telithromycin resistance and also the first time that such a large deletion in the erm(B) upstream region has been identified in S. pneumoniae.

摘要

肺炎链球菌对大环内酯类药物的耐药性通常由erm(B)甲基化基因编码的23S核糖体RNA甲基化介导,或由mef(A)基因介导的外排作用介导。L4和L22核糖体蛋白的变化也与大环内酯类耐药性及替利霉素活性降低有关。本研究从三株肺炎链球菌亲本菌株中产生了体外突变体:02J1175 [mef(A) +]、02J1095 [erm(B) +]和NCTC 1,3593(对大环内酯类药物敏感)。通过PCR扩增了erm(B)及其上游区域、mef(A)基因及其上下游区域、编码结构域II和V的23S rRNA基因以及替利霉素耐药菌株的L4和L22基因,除mef(A)上下游区域外,其余均进行了测序。mef(A) +突变体的任何基因均未出现变化。erm(B) +突变体的erm(B)基因、23S rRNA基因或L4蛋白基因均未发现变化。然而,在一株来自erm(B) +且替利霉素最低抑菌浓度>32 mg/L的突变体中,确实发生了Lys-94至Gln-94的氨基酸突变。该菌株的erm(B)上游区域还存在210个碱基对缺失。我们认为这是首次发现L22中与替利霉素耐药性相关的Lys-94至Gln-94变化,也是首次在肺炎链球菌中鉴定出erm(B)上游区域如此大的缺失。

相似文献

1
High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.肺炎链球菌实验室诱导突变体中的高水平替利霉素耐药性。
J Antimicrob Chemother. 2003 Sep;52(3):345-53. doi: 10.1093/jac/dkg348. Epub 2003 Aug 13.
2
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.两种新型大环内酯类药物GW 773546和GW 708408与红霉素、阿奇霉素、克拉霉素、克林霉素和泰利霉素相比的抗肺炎球菌活性。
Antimicrob Agents Chemother. 2004 Nov;48(11):4103-12. doi: 10.1128/AAC.48.11.4103-4112.2004.
3
Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).在加拿大呼吸道病原体药敏试验(CROSS,1998 - 2004年)的6年期间分离出的肺炎链球菌中的大环内酯类耐药机制。
J Antimicrob Chemother. 2007 Oct;60(4):733-40. doi: 10.1093/jac/dkm273. Epub 2007 Aug 2.
4
Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.16元环大环内酯类药物及泰利霉素对不同基因型的红霉素敏感及耐药化脓性链球菌和肺炎链球菌的活性。
J Antimicrob Chemother. 2007 Jun;59(6):1171-6. doi: 10.1093/jac/dkm089. Epub 2007 Apr 3.
5
Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.比利时肺炎链球菌分离株中的大环内酯类耐药机制
Clin Microbiol Infect. 2005 Apr;11(4):332-4. doi: 10.1111/j.1469-0691.2005.01077.x.
6
Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.1998 - 1999年加拿大耐大环内酯类肺炎链球菌:mef(A)和erm(B)的流行情况以及对酮内酯类的敏感性
Antimicrob Agents Chemother. 2001 Jul;45(7):2147-50. doi: 10.1128/AAC.45.7.2147-2150.2001.
7
Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.泰利霉素对大环内酯类耐药和敏感的肺炎链球菌、卡他莫拉菌及流感嗜血杆菌的体外活性比较
J Antimicrob Chemother. 2004 May;53(5):793-6. doi: 10.1093/jac/dkh178. Epub 2004 Mar 31.
8
Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations.模拟临床可达到的游离血清和上皮衬液浓度时,泰利霉素对大环内酯类敏感和耐药肺炎链球菌的药效学活性。
J Antimicrob Chemother. 2004 Dec;54(6):1072-7. doi: 10.1093/jac/dkh475. Epub 2004 Nov 5.
9
Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.化脓性链球菌和肺炎链球菌对大环内酯类药物及泰利霉素的敏感性:一项意大利多中心研究的数据。
J Chemother. 2007 Oct;19(5):500-7. doi: 10.1179/joc.2007.19.5.500.
10
Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.韩国耐红霉素肺炎链球菌的特征以及泰利霉素对耐红霉素肺炎链球菌的体外活性
Microb Drug Resist. 2005 Fall;11(3):260-5. doi: 10.1089/mdr.2005.11.260.

引用本文的文献

1
New Resistance Mutations Linked to Decreased Susceptibility to Solithromycin in Streptococcus pneumoniae Revealed by Chemogenomic Screens.通过化学生物基因组筛选发现肺炎链球菌中新的耐药突变与索利霉素敏感性降低有关。
Antimicrob Agents Chemother. 2023 Aug 17;67(8):e0039523. doi: 10.1128/aac.00395-23. Epub 2023 Jul 6.
2
Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin.具有 erm 介导的组成型大环内酯-林可酰胺-链阳性菌素 B 耐药表型的金黄色葡萄球菌对新型酮内酯类药物索利霉素的敏感性降低。
BMC Infect Dis. 2019 Feb 19;19(1):175. doi: 10.1186/s12879-019-3779-8.
3
In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.
α-甲氧基氨基酰化物衍生物对大环内酯类耐药病原体的体外抗菌活性及23S rRNA的突变分析
J Antibiot (Tokyo). 2017 Mar;70(3):264-271. doi: 10.1038/ja.2016.148. Epub 2017 Jan 11.
4
Resistance to Macrolide Antibiotics in Public Health Pathogens.公共卫生病原体对大环内酯类抗生素的耐药性
Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):a025395. doi: 10.1101/cshperspect.a025395.
5
Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.结合疫苗时代前后美国耐抗生素肺炎链球菌的生物学和流行病学特征
Clin Microbiol Rev. 2016 Jul;29(3):525-52. doi: 10.1128/CMR.00058-15.
6
Methylation of 23S rRNA nucleotide G748 by RlmAII methyltransferase renders Streptococcus pneumoniae telithromycin susceptible.RlmAII 甲基转移酶对 23S rRNA 核苷酸 G748 的甲基化使肺炎链球菌对替利霉素敏感。
Antimicrob Agents Chemother. 2013 Aug;57(8):3789-96. doi: 10.1128/AAC.00164-13. Epub 2013 May 28.
7
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.2002年至2006年芬兰侵袭性肺炎链球菌分离株的抗菌药物耐药性和克隆性的时间趋势
Antimicrob Agents Chemother. 2009 May;53(5):2066-73. doi: 10.1128/AAC.01464-08. Epub 2009 Mar 9.
8
Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation.肺炎链球菌对泰利霉素的耐药性是由erm(B)前导序列中的缺失导致的,该缺失增加了rRNA甲基化。
Antimicrob Agents Chemother. 2008 Feb;52(2):435-40. doi: 10.1128/AAC.01074-07. Epub 2007 Dec 3.
9
Genotypes and related factors reflecting macrolide resistance in pneumococcal pneumonia infections in Japan.反映日本肺炎球菌肺炎感染中大环内酯类耐药性的基因型及相关因素
J Clin Microbiol. 2007 May;45(5):1440-6. doi: 10.1128/JCM.01430-06. Epub 2007 Mar 7.
10
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.肺炎链球菌临床分离株中的高水平替利霉素耐药性。
Antimicrob Agents Chemother. 2007 Mar;51(3):1092-5. doi: 10.1128/AAC.01153-06. Epub 2007 Jan 8.